Investigating the drugs to repair injured alveolar epithelial cells using type 2 alveolar epithelial progenitor cells with ABCA3 mutations
Project/Area Number |
16K10056
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Pediatrics
|
Research Institution | Tohoku University |
Principal Investigator |
Ota Chiharu 東北大学, 大学病院, 助教 (00733106)
|
Co-Investigator(Kenkyū-buntansha) |
菊池 敦生 東北大学, 大学病院, 助教 (30447156)
丹藤 由希子 東北大学, 加齢医学研究所, JSPS特別研究員(RPD) (70596212)
木村 正人 東北大学, 大学病院, 助教 (80646894)
|
Project Period (FY) |
2016-04-01 – 2020-03-31
|
Project Status |
Completed (Fiscal Year 2019)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2018: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 肺胞上皮細胞 / 遺伝性間質性肺炎 / ABCA3 / 肺胞上皮前駆細胞 / 肺胞傷害 / 肺胞修復 / 肺線維化 / 分化誘導法 / サーファクタント / 小児 / 肺胞上皮幹細胞 / 薬物スクリーニング / 薬剤スクリーニング / FACS / サーファクタント蛋白 / 2型肺胞上皮細胞 / 小児間質性肺炎 |
Outline of Final Research Achievements |
Patients with homozygous or compound heterozygous mutations in ABCA3 gene cause severe lung diseases in infants and children. We isolated an alveolar epithelial progenitor cells (AEPCs) from human lungs. In the present study, we isolated AEPCs from 2 patients without ABCA3 mutations and from 2 patients with different ABCA3 mutations and analyzed the differentially expressed genes of the two groups. We evaluated the differentially expressed genes of AT2 derived from ABCA3-wt- and ABCA3-mt-AEPCs. Changes of cell polarity and epithelial barrier function, development associated genes in AT2 with ABCA3 mutation might be involved in the disease development.
|
Academic Significance and Societal Importance of the Research Achievements |
本研究の成果は,ABCA3変異によって起こっていると考えられる肺胞上皮細胞(AT2) 機能障害を,AT2 の前駆細胞AEPCsを用いて再現したところである.本研究の成果を用い,ABCA3変異によって生じるAT2機能障害をターゲットとして,AT2 の機能を改善するという新規視点による治療薬開発を目指すことができる.また,ABCA3 は肺ではAT2 に特異的な遺伝子であるため,ABCA3変異の解析はAT2傷害による難治性肺疾患のメカニズム解明につながる可能性がある.
|
Report
(5 results)
Research Products
(13 results)
-
-
-
-
-
-
-
[Journal Article] Expression of cytochrome P450 mRNAs in Type II alveolar cells from subjects with chronic obstructive pulmonary disease.2018
Author(s)
Kamata S, Fujino N, Yamada M, Grime K, Suzuki S, Ota C, Tando Y, Okada Y, Sakurada A, Noda M, Matsuda Y, Sugiura H, Ichinose M.
-
Journal Title
Pharmacol Res Perspect.
Volume: 6
Pages: 1-7
Related Report
-
[Journal Article] Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo2017
Author(s)
Lehmann M, Korfei M, Mutze K, Klee S, Skronska-Wasek W, Alsafadi HN, Ota C, Costa R, Schiller HB, Lindner M, Wagner DE, Guenther A, Koenigshoff M
-
Journal Title
European Respiratory Journal
Volume: 50
Issue: 2
Pages: 1-7
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-